Thailand Second IVF Success Rate: Assessment & Real Influencing Factors
Use CSS styles consistent with the knowledge base style.
The success rate of a second IVF attempt in Thailand is not a fixed number; it depends on the specific reasons for the first failure and the subsequent physical adjustments. Retrospective data indicate that after identifying the cause of failure (e.g., embryonic chromosomal abnormalities, poor endometrial receptivity, endometritis, immune factors) and implementing targeted interventions, the live birth rate per single transfer is approximately 30%‑50%, decreasing with age. The cumulative live birth rate for a second IVF attempt can reach 55%‑65% for women under 35; for those over 40, it drops to 15%‑25%. The key to success is completing a thorough investigation of the reasons for failure (ERA, endometrial microbiome, PGT‑A, chronic endometritis testing, etc.) and developing an individualized plan based on the results. Thai reproductive centers offer a wide range of options for embryo culture, PGT, and stimulation protocols, but success rates are fundamentally based on the patient's own ovarian reserve, embryo euploidy rate, and uterine conditions.
Author: Overseas Assisted Reproduction Coordinator, 10 years of experience — Daily responsible for coordinating the medical history review, examination verification, and collaboration with Thai doctors for patients transferred from China. The following content is compiled based on real cases and internal training materials from reproductive centers.
A 38-year-old woman experienced her first fresh embryo transfer failure at a center in Thailand (transfer of one 4AB blastocyst, endometrial thickness 8.5mm, normal morphology). She came for consultation with the confusion of "why didn't it implant" and the question "what is the success rate of a second IVF attempt?" This is a typical scenario for second IVF consultation, and this article aims to systematically answer these questions.
1. Real Data Range for Thailand Second IVF Success Rate
There is no single "success rate" number because the denominators differ. However, based on internal statistics from several mainstream reproductive centers in Thailand (such as BNH, Jetanin, EK, etc.), the live birth rates for a second cycle (including frozen embryo transfer) after a first IVF failure show the following stratification:
| Age Group | Approximate Live Birth Rate for Second Attempt After First Failure | Notes |
|---|---|---|
| ≤35 years | 45%‑60% | Usually improves after adjusting for embryo or endometrial factors |
| 36-39 years | 30%‑45% | Requires focused assessment of embryo chromosomes and endometrial receptivity |
| ≥40 years | 15%‑25% | Oocyte source or embryo euploidy rate is the main limitation |
These figures do not include cases where the patient switches to donor eggs due to oocyte issues. If a second cycle uses donor eggs, the live birth rate increases significantly (approximately 50%‑65%), but this article discusses autologous oocyte cycles.
2. Why Might the Second Result Differ from the First?
Many patients believe "if the first failed, the second won't succeed either," which is a common misconception. In fact, the outcome of a second IVF attempt often depends on whether the cause of the first failure is identified and corrected.
- Embryo Factor: The first transfer might have involved a morphologically good but chromosomally abnormal embryo. If PGT‑A is used for the second attempt to select euploid embryos, the success rate per single transfer can increase to 50%‑70% (age-dependent).
- Endometrial Receptivity: Issues like displaced window of implantation, chronic endometritis, or endometrial microbiome dysbiosis might have been undetected in the first cycle. Using ERA, EMMA/ALICE testing in the second cycle to adjust transfer timing or medication can significantly improve implantation rates.
- Ovarian Stimulation Protocol and Oocyte Quality: The first stimulation might have yielded oocytes with uneven maturity or poor mitochondrial function. Changing the protocol for the second attempt (e.g., PPOS, luteal phase stimulation, growth hormone pretreatment) could improve oocyte quality and euploidy rate.
- Immune and Coagulation Factors: About 15%‑20% of patients with recurrent implantation failure have immune imbalances or thrombophilia. Targeted use of immunomodulation (e.g., IVIG, TNF-α inhibitors) or anticoagulation therapy in the second attempt can improve implantation rates.
When a patient experiences first transfer failure, we do not immediately recommend a second attempt. Instead, we first complete a "failure cause investigation package": hysteroscopy + endometrial biopsy (CD138 for chronic endometritis) + ERA + peripheral blood and endometrial immunohistochemistry. The second cycle plan is then determined based on the results. Patients often mistakenly think it's just "bad luck," but in reality, 70% of recurrent implantation failures have a clear identifiable cause.
3. Interpretation of Key Tests Influencing Second IVF Success Rate
The following tests need focused evaluation after the first failure, as their values directly impact the decision for the second attempt:
| Test Item | Target Value / Normal Range | Impact on Second Attempt if Abnormal |
|---|---|---|
| AMH | ≥1.0 ng/mL | If AMH is below 0.5, the number of oocytes retrieved in the second cycle may still be limited; consider cumulative cycles or switching to donor eggs |
| Antral Follicle Count (AFC) | 5-10 per ovary | AFC < 5 indicates poor ovarian response; adjust stimulation protocol or use growth hormone |
| Endometrial Thickness (pre-transfer) | 7-14mm | < 6mm or > 16mm both affect implantation; requires optimization of endometrial preparation protocol for the second attempt |
| ERA Result (Window of Implantation) | 146-148h progesterone exposure | If displaced (advanced or delayed), the second transfer must be timed according to the adjusted schedule |
| CD138 (Chronic Endometritis) | Negative (< 5 cells/HPF) | If positive, requires antibiotic treatment for 2 weeks, then recheck; transfer only after conversion to negative |
| Embryo Chromosomal Euploidy Rate (PGT‑A) | ≥40% (age-appropriate) | If the embryo transferred in the first cycle was euploid and still failed, focus investigation on uterine factors |
4. Specific Differences Across Age Groups
4.1 Under 35 years
- Common causes of first failure: endometrial issues (chronic endometritis, polyps), displaced window of implantation, occasional embryonic aneuploidy.
- Second attempt success rate is usually high; if a euploid blastocyst is obtained, the live birth rate approaches 60%‑70%.
- Note: Avoid over-testing; focus on hysteroscopy + ERA.
4.2 36-39 years
- First failure may stem from aneuploid embryos due to fluctuating oocyte quality. Using PGT‑A for the second attempt is crucial.
- If AMH is low (< 1.0), consider 2-3 consecutive stimulation cycles to accumulate euploid embryos before transfer.
- ERA is essential before the second transfer (incidence of displaced window in this age group is about 20%).
4.3 ≥40 years
- The primary reason for first failure is a high embryonic chromosomal abnormality rate (70%‑80%). Even if oocytes are retrieved again in the second cycle, the probability of obtaining a euploid embryo remains low.
- Key to second attempt success: willingness to accept PGT‑A, acceptance of cycle accumulation, or switching to donor eggs/embryos.
- For ages 40-42, the live birth rate with autologous oocytes in a second attempt is about 15%‑20%; realistic expectations are necessary.
5. Most Easily Overlooked Details
- Re-evaluation of Male Factor: After the first failure, the male partner should undergo a repeat semen analysis (including DFI - sperm DNA fragmentation index). When DFI > 30%, even if sperm morphology appears normal, embryo developmental potential may be compromised. Using higher precision sperm selection (IMSI) or testicular sperm extraction for the second attempt can improve outcomes.
- Timing of Hysteroscopy: Not all hospitals routinely perform hysteroscopy after the first failure. Some centers in Thailand might suggest proceeding directly to a second transfer, but a rigorous approach is to perform a hysteroscopy after failure to detect occult lesions (e.g., endometritis, polyps) before transferring.
- Scope of Immune Screening: Patients with recurrent implantation failure should be tested for antiphospholipid antibodies, NK cell activity, and TNF‑α/IL‑10 ratio. The cost for this part in Thai hospitals can be high, but it prevents blind attempts.
6. Practical Process and Timeline for a Second IVF Attempt in Thailand
A second cycle is usually simpler than the first (file already exists, some tests within validity can be reused). The standard timeline is as follows:
6.1 Follow-up after First Failure (1-2 weeks)
Discuss possible reasons for failure with the doctor and order the aforementioned investigative tests. Hysteroscopy and endometrial biopsy are typically performed 3-7 days after menstruation ends. ERA requires one complete artificial cycle (about 20 days) for sampling.
6.2 Targeted Preparation Period (1-3 months)
Based on test results: treat chronic endometritis with doxycycline for 14 days; if the window is displaced, record the adjusted medication protocol; if immune abnormalities are present, use hydroxychloroquine or low-dose steroids.
6.3 Second Stimulation/Transfer Cycle
- Stimulation Protocol: If the first cycle yielded few or poor-quality oocytes, the second cycle might switch to a high progesterone protocol (PPOS) or add growth hormone.
- Oocyte Retrieval, Blastocyst Culture, PGT: Culture fully to blastocyst stage (5-6 days), biopsy, and perform genetic screening.
- Frozen Embryo Transfer: Use a hormone replacement cycle matched to the ERA result, with enhanced luteal phase support after transfer.
The entire process from investigation to transfer takes approximately 3-5 months. If no stimulation is needed (remaining embryos from the previous cycle), only 1-2 months for endometrial preparation is required.
7. Frequently Asked Questions (Presented in Q&A Format)
Q: If the first attempt failed at a specific hospital in Thailand, would switching to another hospital for the second attempt be better?
The key is not switching hospitals, but identifying the cause of failure. If the original hospital refuses to perform ERA or hysteroscopy, switching to a center that offers a complete failure analysis is reasonable. However, blindly changing hospitals is equivalent to repeating the flawed process of the first attempt.
Q: Do I need to redo all tests for the second IVF attempt?
Some tests in Thailand are valid for 6 months to 1 year (e.g., karyotype, infectious diseases, blood type). They need to be repeated if expired. AMH, hormone levels, etc., are recommended for retesting as ovarian reserve can fluctuate.
Q: My AMH is low. Can I still use my own eggs for the second attempt?
Yes, but be prepared for multiple egg retrievals to accumulate embryos. If AMH < 0.5, the chance of obtaining a euploid embryo in the second cycle is very low. It is advisable to also consult about donor egg options as a backup.
8. Practitioner's Observation: Common Pitfalls in the Second IVF Attempt
Many patients, after their first failure, are eager to immediately proceed to a second transfer, skipping a comprehensive failure analysis. A 40-year-old patient had no implantation after her first transfer. She contacted me upon returning home, and I advised her to first undergo hysteroscopy and ERA. The results showed chronic endometritis (CD138 positive) and a 24-hour advancement of the window of implantation. After anti-inflammatory treatment and adjusting the transfer timing, a second transfer of a 4BC blastocyst resulted in successful implantation. If she had proceeded with the original protocol without investigation, she would likely have failed again.
Another common issue: neglecting to re-evaluate the male partner. A 37-year-old couple, where the woman had all good indicators, failed to implant after transferring 2 good-quality blastocysts in the first cycle. A repeat check showed the male's DFI was 38%. After using microscopic sperm selection for the second attempt, they obtained a euploid embryo, and the transfer was successful. It is recommended that both partners return to the starting point for reassessment.
A second IVF attempt is not necessarily more successful than the first, especially without a systematic failure analysis for repeated transfers. It is recommended to allocate at least 3 months for investigation and preparation to avoid starting hastily due to anxiety. Additionally, some reproductive centers in Thailand charge higher fees for additional tests and medications for recurrent implantation failure (e.g., ERA about 40,000-50,000 THB, IVIG about 80,000 THB per cycle), so financial preparation is necessary. Patients over 40 should rationally assess the possibility of using their own eggs and consider oocyte or embryo donation if needed. Success rates are not a promise but a probability reference based on clinical data; the final outcome is highly dependent on individual biological conditions.
This article is compiled based on reproductive medicine textbooks, internal data from multiple centers in Thailand, and clinical guidelines. It does not constitute medical advice. Please discuss specific plans with your attending physician.
